IV Brazilian Consensus on Rhinitis – an update on allergic rhinitis

Sakano, Eulália; Sarinho, Emanuel; Cruz, Álvaro Augusto; Pastorino, Antônio Carlos; Tamashiro, Edwin; Kuschnir, Fábio Chigres; Castro, Fábio Fernandes Morato; Romano, Fabrizio Ricci; Wandalsen, Gustavo F.; Chong-Neto, Herberto José; Mello, João Ferreira de; Silva, Luciana Rodrígues; Rizzo, Maria Cândida; Miyake, Monica Aidar Menon; Filho, Nelson Augusto Rosário; Rubini, Norma de Paula Motta; Mion, Olavo; Camargos, Paulo Augusto Moreira; Roithmann, Renato; Godinho, Ricardo; Pignatari, Shirley Shizue Nagata; Sih, Tânia; Anselmo-Lima, Wilma Teresinha; Solé, Dírceu

doi:10.1016/j.bjorl.2017.10.006

Cited by 35 publications

(43 citation statements)

References 96 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Apesar de alguns fatores socioambientais como: o convívio com tabagistas, a presença de animais de penas e/ou pelos na moradia em que reside, a presença de fungos/mofo nas paredes de 1 ou mais cômodos de sua residência, desencadearem de reações alérgicas respiratórias que levam à obstrução nasal 18,19 , não foi identificado associação (valor-p >0,05) entre esses fatores e a utilização de DNT por automedicação entre os estudantes.…”

Section: Resultsunclassified

Descongestionantes nasais tópicos por automedicação e a autopercepção da qualidade de vida por universitários de cursos de saúde / Topical nasal decongestants through self-medication and self-perception of quality of life by students of health occupations

Rodrigues

Freitas

Carneiro

et al. 2020

BJHR

View full text Add to dashboard Cite

RESUMOObjetivo: Estudar a prevalência do uso de descongestionantes nasais tópicos por automedicação e a auto percepção da qualidade de vida pelos acadêmicos da graduação em áreas da saúde da Universidade Federal do Amazonas, em Manaus-Amazonas-Brasil. Métodos: Estudo transversal de natureza qualitativa e quantitativa. A coleta de dados consistiu na aplicação de questionário estruturado pela própria equipe de pesquisa e do Índice de 8 itens EuroHisQol 8, versão validada e traduzida para o português. Para análise estatística utilizou-se o teste qui-quadrado e o teste exato de Fisher, com nível de significância de 5%. Resultados: Dos 279 participantes, 69,9% já se automedicaram com descongestionantes. Aqueles já diagnosticados com doenças nasais crônicas e os que já consultaram ou receberam orientação médica acerca do fármaco, em momento anterior ao uso, foram mais propensos a utilizar o medicamento por automedicação (p <0,05). Em relação à qualidade de vida, o valor médio obtido foi 3,42 (± 0,97) para os estudantes que fizeram uso dos descongestionantes e 3,29 (± 0,96) para os que não fizeram. Conclusão: O uso de descongestionantes nasais tópicos por automedicação entre estudantes das áreas da saúde é elevado, mesmo sendo um grupo que possua acesso à informação de qualidade. Parece, contudo, não haver diferença estatística significativa em relação a auto percepção de qualidade de vida entre os participantes que se automedicaram e os que não se automedicaram, possivelmente, essa relação entre qualidade respiratória e qualidade de vida precise ser melhor esclarecida em pesquisas futuras.

show abstract

Section: Resultsunclassified

Descongestionantes nasais tópicos por automedicação e a autopercepção da qualidade de vida por universitários de cursos de saúde / Topical nasal decongestants through self-medication and self-perception of quality of life by students of health occupations

Rodrigues

Freitas

Carneiro

et al. 2020

BJHR

View full text Add to dashboard Cite

show abstract

“…Mild symptoms do not interfere with sleep or daily activities, while moderate to severe symptoms can cause sleep disturbances and work/life disorders. At present, although there are many treatment options, including oral drugs, topical sprays, and intranasal corticosteroids are the main treatment 19 , but they are not effective for some patients. In addition to basic symptoms such as nasal symptoms and nosebleeds, the use of these drugs is contraindicated in some patients, such as pregnant or nursing women.…”

Section: Discussionmentioning

confidence: 99%

Effect and mechanism of human umbilical cord mesenchymal stem cells in treating allergic rhinitis in mice

Kan

Pan

Zhao

et al. 2020

Sci Rep

View full text Add to dashboard Cite

A model of allergic rhinitis (AR) in BALB/c mice was established and evaluated to provide experimental subjects for further research. Preparation of human umbilical cord mesenchymal stem cells (hUCMSCs), including isolation, expansion culture, passaging, cryopreservation, and preparation of cell suspensions, provided materials for experimental research and clinical treatment. The mouse AR model was established by ovalbumin (OVA) intraperitoneal injection and the nasal stimulation induction method, and the model had a good effect and high repeatability. GFP-labeled hUCMSCs had good effects and were stable cells that could be used for tracking in animals. Transplantation of hUCMSCs by intraperitoneal and tail vein injections had a specific effect on the AR model of mice, and tail vein injection had a better effect. Tracking of hUCMSCs in vivo showed that the three groups of mice had the greatest number of hUCMSCs in the nose at week 2. The mouse AR model was used to evaluate the efficacy of hUCMSC transplantation via multiple methods for AR. The distribution of hUCMSCs in vivo was tracked by detecting green fluorescent protein (GFP), and the treatment mechanism of hUCMSCs was elucidated. This study provides technical methods and a theoretical basis for the clinical application of hUCMSCs.

show abstract

“…Saline solutions, for example, have become popular as they are inexpensive, practical, and well-tolerated, although more studies are required. 8,17,18 On the other hand, from the microbiological point of view, it is believed that IDDDs may not be safe, especially since during drug or saline solution delivery in domestic environments, direct contact between the face of the IDDD and the nasal mucosa can occur, which risks contamination and/or recontamination in the individual. To prevent this from happening, it is necessary that the user be properly instructed in relation to maintaining hygiene with the IDDD making direct contact with the nasal mucosa.…”

Section: Intranasal Drug Delivery Devices Are a Potential Contaminatimentioning

confidence: 99%

Intranasal drug delivery devices are a potential contamination source of airways

Pereira¹,

Soares²,

Innocencio³

et al. 2019

Brazilian Journal of Allergy and Immunology (BJAI)

View full text Add to dashboard Cite

Background: The use of intranasal drug delivery devices (IDDD) for the treatment of allergic rhinitis (AR) is frequent because they are simple, efficient, and safe, and mainly because they are perceived as low-risk. However, it is speculated that contact between the nasal mucosa and an IDDD may give rise to infections once the nose is colonized by bacteria, and there are currently no proper instructions for IDDD sanitization. The objective of this study was to evaluate the possibility of contamination of an IDDD for topical medication after simulating use in healthy individuals. Methods: The in vitro study consisted of 14 healthy individuals of both sexes, between the ages of 18 and 24 years. Samples were collected immediately after the opening of each IDDD and after simulating use by the subjects. Afterwards, the samples were deposited in tubes and kept in an incubator at 37 °C. After 48 hours, the samples were inoculated on Müller-Hinton agar. Qualitative analyses of the appearance of the samples were performed after 24 and 48 hours, and after 72 hours the presence or absence of bacteria was evaluated macroscopically. Results: After 24 hours of incubation, 21.4% (n = 3) of the samples presented with a turbid appearance and after 48h, 71% (n = 10) of the samples presented with a turbid appearance and positive bacterial growth. Conclusion: The results suggest that IDDDs for topical medications may be important sources of contamination or recontamination of the nasal mucosa of individuals who are being treated for upper respiratory tract conditions. A better understanding of the risks of re-using IDDDs after previous contact with the nasal mucosa will improve guidelines on hygiene procedures and prevention of related risks.

show abstract

IV Brazilian Consensus on Rhinitis – an update on allergic rhinitis

Abstract: A flowchart for allergic rhinitis treatment has been proposed.

Cited by 35 publications

References 96 publications

Descongestionantes nasais tópicos por automedicação e a autopercepção da qualidade de vida por universitários de cursos de saúde / Topical nasal decongestants through self-medication and self-perception of quality of life by students of health occupations

Descongestionantes nasais tópicos por automedicação e a autopercepção da qualidade de vida por universitários de cursos de saúde / Topical nasal decongestants through self-medication and self-perception of quality of life by students of health occupations

Effect and mechanism of human umbilical cord mesenchymal stem cells in treating allergic rhinitis in mice

Intranasal drug delivery devices are a potential contamination source of airways

Contact Info

Product

Resources

About